OCT 18, 2018 06:37 AM PDT

Potential Drug Target for Tactile Allodynia

WRITTEN BY: Nouran Amin

According to research published in the journal Science Translational Medicine in collaboration with a study led by the National Institutes of Health, a new protein found in neuronal cells was identified by researchers at Scripps Research to be implicated in tactile allodynia; a painful sensation caused by light touch and often associated with neuropathy.

Watch Video Below To Learn More about Tactile Allodynia:

The protein identified is PIEZO2 which was originally discovered in the laboratory of Professor Ardem Patapoutian, who worked significantly on the role of allodynia in mice. These studies also confirmed that PIEZO2 was responsible for allodynia in humans. “These two studies provide validation that targeting PIEZO2 could be beneficial in the clinic,” explains Prof. Patapoutian.

During the studies, researchers had used various induction methods for allodynia including the utilization of a neuronal sensitive chemical molecule, capsacin, which is found in a chili pepper, and known to cause inflammation. “We hope that these results will help researchers develop better treatments for managing this common form of pain,” said study author Alexander T. Chesler, PhD, who is also a Stadtman Investigator at the NIH’s National Center for Complementary and Integrative Health (NCCIH).

Image via Drug Target Review

Furthermore, first author of the study—Dr. Swetha Murthy had examined the research to focus on mice who had gentle reactions to touch after exposure to capsaicin. Findings concluded that non-genetically altered normal mice had experienced allodynia. However, the mice that were altered, or had the PIEZO2 gene “knocked out”, did not experience allodynia by not reacting to the capsaicin exposure. Additionally, the findings were also exhibited in human patients who had mutations in their PIEZO2 gene expression. “It was very gratifying to see this in both studies,” says Dr. Murthy. “It usually takes years to confirm if results observed in mice hold true in humans, so I think it was mutually exciting for both groups.”

The researchers are looking forward to examine exactly how inflammation is implicated with normal touch signals and to determine a cause. They also wish to identify potential molecules that can act as PIEZO2 blockers that may one day relieve patients from neuropathic pain.

Source: Science Transitional Method, Drug Target Review

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Injectable Hydrogel Recruits Chemotherapeutics to Tumor Site
Targeting tumor cells while avoiding harming healthy tissue remains a growing central challenge in the field of chemotherapeutics. For a while, scientists ...
SEP 20, 2019
Health & Medicine
SEP 20, 2019
Remember Joe Camel? E-cigarette cartoon ads increase the chances of vaping
Do you remember the infamous "Joe Camel" advertisements for cigarettes back in the 1980s and 90s? These ads successfully got a generation of youn...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Effective Treatment for Ulveal Melanoma
Uveal melanoma is a rare and aggressive type of melanoma that targets the eye and affects an estimated 2,500 people in the United States annually. Nearly h...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
What's the Difference Between Therapy and MDMA Therapy?
From a first glance, MDMA-assisted therapy may look very different from mainstream therapies such as Cognitive Behavioral Therapy (CBT); patients lying on...
SEP 20, 2019
Technology
SEP 20, 2019
Computer Model Advances New Therapeutics for Sickle Cell Anemia
A team of Brown University researchers has developed a new computer model that simulates the way red blood cells become misshapen by sickle cell anemia. A ...
SEP 20, 2019
Genetics & Genomics
SEP 20, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
Loading Comments...